1)日本呼吸器学会(編):特発性間質性肺炎診断と治療の手引き.南江堂,2004
2)日本呼吸器学会(編):薬剤性肺障害の評価,治療についてのガイドライン.メディカルレビュー社,2005
3)Van Oortegem K, Wallaert B, Marquette CH, et al:Determinants of response to immunosuppressive therapy in idiopathic pulmonary fibrosis.Eur Respir J 7, 1994
4)Kinder BW, Brown KK, Schwarz KI, et al:Baseline BAL Neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133, 2008
5)Lama VN, Flaherty KR, Towes GB, et al:Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168:1084, 2003
6)Walter N, Collard HR, et al:Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3:330, 2006
7)Mortenson RL, Panos RJ, King:TE Jr:Idiopathic pulmonary fibrosis.In Pulmonary and Critical Care Medicine, Bone, RC(ed), St. Louis, Mosby Year Book, 1993
8)Keogh BA, Bernardo J, Hunninghake GW, et al:Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 127:18, 1983
9)Kolb M, Kirschner J, Riedel W, et al:Cyclophosphamide pulse therapy in idiopathic pulmonary fibrosis.Eur Respir J 12:1409, 1998
10)Flaherty KR, Towes GB, Lynch JP, 3rd, et al:Steroids in idiopathic pulmonary fibrosis:a prospective assessment of adverse reactions, response to therapy, and survival. Am J Med 110:278, 2001